Table 2. KEGG pathways of differentially expressed genes in Panc02 tumors induced by enriched environment.
| No. | Term | Count | P | PFDR |
|---|---|---|---|---|
| 1 | Citrate cyclea | 17 | 4.30E-23 | 4.52E-20 |
| 2 | Parkinson's disease | 22 | 8.86E-18 | 9.32E-15 |
| 3 | Oxidative phosphorylationa | 21 | 1.03E-16 | 1.22E-13 |
| 4 | Alzheimer's disease | 23 | 4.62E-16 | 4.66E-13 |
| 5 | Huntington's disease | 23 | 5.20E-16 | 5.88E-13 |
| 6 | Pyruvate metabolisma | 9 | 4.38E-08 | 4.61E-05 |
| 7 | Propanoate metabolisma | 8 | 8.62E-08 | 9.07E-05 |
| 8 | Cardiac muscle contraction | 9 | 7.25E-06 | 0.007632 |
| 9 | Fatty acid metabolisma | 7 | 2.39E-05 | 0.025154 |
| 10 | Valine, leucine and isoleucine degradationa | 7 | 2.72E-05 | 0.028625 |
| 11 | Glycolysis/Gluconeogenesisa | 8 | 2.74E-05 | 0.028881 |
| 12 | Glyoxylate and dicarboxylate metabolisma | 5 | 4.59E-05 | 0.048242 |
aMitochondria-related pathways.
PFDR: false discovery rate corrected P value.